Regenerx Biopharmaceuticals Inc (RGRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2022 | 12-2021 | 12-2020 | 12-2019 | 12-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 291 | 1,232 | 428 | 640 | 237 |
| TOTAL | $307 | $1,252 | $478 | $682 | $274 |
| Non-Current Assets | |||||
| PPE Net | N/A | N/A | N/A | N/A | 1 |
| Other Non-Current Assets | 75 | 33 | 74 | 30 | 6 |
| TOTAL | $75 | $33 | $74 | $30 | $7 |
| Total Assets | $382 | $1,285 | $552 | $712 | $281 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | 34 | 0 | N/A |
| Accounts payable and accrued liabilities | 64 | 64 | 39 | 44 | 92 |
| Accrued Expenses | 370 | 262 | 209 | 95 | 91 |
| TOTAL | $554 | $430 | $400 | $243 | $315 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | 22 | 0 | N/A |
| Deferred Revenues | 77 | 77 | 77 | 77 | 77 |
| Other Non-Current Liabilities | 1,403 | 1,137 | 930 | 708 | 0 |
| TOTAL | $3,274 | $3,085 | $2,976 | $2,809 | $2,178 |
| Total Liabilities | $3,828 | $3,515 | $3,376 | $3,052 | $2,493 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,435 | 1,435 | 1,335 | 1,334 | 1,296 |
| Common Shares | 144 | 144 | 133 | 132 | 128 |
| Retained earnings | -112,217 | -110,490 | -108,892 | -107,369 | -105,882 |
| TOTAL | $-3,446 | $-2,230 | $-2,824 | $-2,340 | $-2,212 |
| Total Liabilities And Equity | $382 | $1,285 | $552 | $712 | $281 |